{
  "chapter": "Gastrointestinal System-Malabsorption Syndromes",
  "questions": [
    {
      "q_no": 1,
      "question": "A 32-year-old female presents to the clinic with complaints of chronic diarrhea, bloating, abdominal pain, and unintentional weight loss for the past few months. She mentions that these symptoms worsen after consuming foods containing barley. Laboratory investigations reveal iron deficiency anemia and elevated tissue transglutaminase antibodies (tTG-IgA). Which of the following will be the appropriate treatment for this patient?",
      "options": {
        "A": "Initiating a diet rich in barley to assess tolerance",
        "B": "Starting a gluten-free diet",
        "C": "Prescribing antibiotics to treat potential bacterial overgrowth",
        "D": "Administering corticosteroids to reduce inflammation"
      },
      "correct_answer": "B",
      "explanation": "present in wheat, rye, barley, and certain oat varieties, triggers immune-mediated damage in affected individuals. A gluten-free diet is the cornerstone of management for celiac disease, as it helps alleviate symptoms, promote mucosal healing, and prevent long-term complications. Gluten-free options like potatoes, rice, corn, soy, nuts, quinoa, and beans are safe to eat for those with celiac disease. Initiating a diet rich in barley to assess tolerance (Option A): This option is not appropriate for a patient with suspected celiac sprue, as barley contains gluten, which is known to exacerbate symptoms in individuals with gluten sensitivity or celiac disease. Consuming barley-containing foods would likely worsen the patient's condition. Prescribing antibiotics to treat potential bacterial overgrowth (Option C): While bacterial overgrowth can contribute to gastrointestinal symptoms, it is not the primary cause of symptoms in celiac disease. Therefore, prescribing antibiotics would not address the underlying pathology of gluten sensitivity. Administering corticosteroids to reduce inflammation (Option D): Corticosteroids may be used in certain cases of refractory celiac disease or severe inflammation; however, they are not typically the first-line treatment for uncomplicated celiac disease. The primary treatment approach involves dietary modification with a gluten-free diet. Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 2464",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Gastrointestinal System-Malabsorption Syndromes"
    },
    {
      "q_no": 2,
      "question": "A 35-year-old female presents with chronic diarrhea, bloating, and weight loss over the past few months. She reports feeling fatigued despite adequate rest. Physical examination reveals mild pallor and abdominal distension. Laboratory investigations show microcytic anemia with low serum iron and ferritin levels. The physician suspects a malabsorption syndrome. Which of the following diagnostic tests would confirm the diagnosis of celiac disease in this patient?",
      "options": {
        "A": "Upper gastrointestinal endoscopy with biopsy of duodenal mucosa",
        "B": "Colonoscopy with biopsy of colonic mucosa",
        "C": "Stool antigen testing",
        "D": "Hydrogen breath test for lactose intolerance"
      },
      "correct_answer": "A",
      "explanation": "duodenum only or widespread jejunal disease leading to severe symptoms. The most appropriate diagnostic test to confirm celiac disease in this patient is serologic testing for specific antibodies, including: Tissue transglutaminase (tTG) antibodies Anti-endomysial antibodies (EMA) Anti-gliadin antibodies (AGA) These serologic tests are sensitive and specific for celiac disease. If the serologic tests are positive, further confirmation is typically achieved through upper gastrointestinal endoscopy with a biopsy of the duodenal mucosa. This procedure reveals characteristic histopathological changes such as villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis. villous atrophy in celiac disease\" data-author=\"GeneFood\" data-hash=\"9397\" data-license=\"CC BY 4.0\" data-source=\"https://commons.wikimedia.org/wiki/File:Histopathology_of_villous_atrophy_in_celiac_di sease.jpg\" data-tags=\"April2025\" height=\"313\" src=\"https://image.prepladder.com/notes/Gy4hyUECywB8HFOVQmgj1744374391.png\" width=\"595\" /> Colonoscopy with biopsy of colonic mucosa (Option B): Colonoscopy with colonic mucosa biopsy is not indicated for diagnosing celiac disease. Celiac disease primarily affects the small intestine, particularly the duodenum. While some gastrointestinal symptoms may overlap with those of inflammatory bowel disease (IBD), the characteristic histological changes of celiac disease are not observed in the colon. Stool antigen testing (Option C): Stool antigen testing is used to diagnose H. pylori infection, which can cause peptic ulcers and gastritis. It is not relevant to diagnosing celiac disease, an autoimmune disorder primarily affecting the small intestine. Hydrogen breath test for lactose intolerance (Option D): Hydrogen breath testing is used to diagnose lactose intolerance by measuring the amount of hydrogen gas produced by bacteria in the colon when lactose is fermented. While some individuals with celiac disease may also have lactose intolerance due to secondary lactase deficiency, a hydrogen breath test is not specific for celiac disease diagnosis. Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 2463",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Gastrointestinal System-Malabsorption Syndromes"
    },
    {
      "q_no": 3,
      "question": "A 28-year-old female presents with chronic diarrhea, abdominal bloating, and fatigue for several months. She reports irregular bowel habits and unintentional weight loss. Laboratory investigations reveal microcytic anemia with low serum iron and ferritin levels. Serological testing shows elevated levels of anti-tissue transglutaminase antibodies (anti-tTG IgA). A small intestinal mucosal biopsy is performed, revealing histopathological changes consistent with hyperplastic crypts with partial villous atrophy. Which of the following Marsh classifications best describes the histopathological findings in this patient?",
      "options": {
        "A": "Type II",
        "B": "Type IIIa",
        "C": "Type IIIb",
        "D": "Type IIIc"
      },
      "correct_answer": "B",
      "explanation": "intestinal mucosa of individuals with celiac disease. It enables the assessment of damage severity resulting from the autoimmune reaction to gluten intake. Type Definition 0 Normal duodenal biopsy I Normal mucosal architecture with increased intraepithelial lymphocytes II (Option A ruled out) Hyperplastic crypts, but near normal Villi IIIa (Option B) Hyperplastic crypts with partial villous atrophy IIIb (Option C ruled out) Hyperplastic crypts with subtotal villous atrophy IIIc (Option D ruled out) Hyperplastic crypts with total villous atrophy Reference: https://www.researchgate.net/figure/Modified-Marsh-classification-of-celiac-disease_tbl1_8505308",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Gastrointestinal System-Malabsorption Syndromes"
    },
    {
      "q_no": 4,
      "question": "A 45-year-old male presents with chronic diarrhea, steatorrhea, and weight loss over the past few months. Upon further evaluation, he is found to have deficiencies in fat-soluble vitamins. Which of the following mechanisms best explains the underlying cause of his symptoms?",
      "options": {
        "A": "Insufficient bile salt synthesis leads to impaired emulsification of fats.",
        "B": "Reduced absorption of short-chain fatty acids in the colon.",
        "C": "Hyposecretion of fibroblast growth factor 19 (FGF19) causes inhibition of bile acid synthesis.",
        "D": "Defective assembly of chylomicrons due to apolipoprotein deficiency."
      },
      "correct_answer": "A",
      "explanation": "Correct answer: A) Insufficient bile salt synthesis leads to impaired emulsification of fats. droplets that can be more easily digested by pancreatic lipase. Thus, emulsification is essential for the efficient digestion and absorption of dietary fats. Patients with insufficient bile salt synthesis result in an impaired emulsification process and may present with steatorrhea, chronic diarrhea, and deficiencies in fat-soluble vitamins such as vitamins A, D, E, and K, which manifests as night blindness, osteomalacia, neuropathy, and coagulopathy, respectively. Steatorrhea, characterized by bulky, foul-smelling stools containing undigested fat, is a hallmark symptom of fat malabsorption. Reduced absorption of short-chain fatty acids in the colon (Option B): Short-chain fatty acids are primarily produced by bacterial fermentation in the colon and are absorbed locally. Reduced absorption of short-chain fatty acids in the colon is typically associated with conditions such as short bowel syndrome or colonic disorders and may present with symptoms such as diarrhea, abdominal pain, bloating, and electrolyte abnormalities. However, the typical presentation of fat malabsorption, like steatorrhea and fat-soluble vitamin deficiencies, is not seen. Hyposecretion of fibroblast growth factor 19 (FGF19) causes inhibition of bile acid synthesis (Option C): Not hyposecretion, its hypersecretion of fibroblast growth factor 19 (FGF19) causes inhibition of bile acid synthesis by inhibiting the expression of hepatic enzymes by affecting the transcription of hepatic CYP7A1 involved in bile acid production. Defective assembly of chylomicrons due to apolipoprotein deficiency (Option D): Defective assembly of chylomicrons due to apolipoprotein deficiency, such as familial chylomicronemia syndrome, typically results in severe hypertriglyceridemia and recurrent episodes of abdominal pain due to pancreatitis rather than chronic diarrhea and steatorrhea even though fat malabsorption occurs to some extent. Reference: Harrison Principles of Internal Medicine, 21st Edition, Page 2459-2560",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Gastrointestinal System-Malabsorption Syndromes"
    },
    {
      "q_no": 5,
      "question": "A 45-year-old man presents with complaints of joint pain and stiffness persisting for the past 6 years. He also reports significant unintentional weight loss, chronic diarrhea, and intermittent abdominal pain. On examination, he appears malnourished with signs of cachexia. Laboratory investigations reveal anemia and hypoalbuminemia. Biopsy shows PAS-positive macrophages. What condition is most likely responsible for the patient's clinical presentation?",
      "options": {
        "A": "Rheumatoid arthritis",
        "B": "Inflammatory bowel disease",
        "C": "Whipple's disease",
        "D": "Celiac disease"
      },
      "correct_answer": "C",
      "explanation": "weight loss), systemic manifestations (joint pain, anemia, hypoalbuminemia), and the hallmark finding of PAS-positive macrophages on endoscopic biopsy. Whipple’s disease: Rare condition characterized by infiltration of small intestinal mucosa by \"foamy\" macrophages. Macrophages stain positive with periodic acid–Schiff (PAS) reagent. Commonly affects middle-aged Caucasian men. Pathophysiology: Caused by Tropheryma whipplei , a Gram-positive bacillus. Villi are widened and flattened, with densely packed macrophages in the lamina propria, obstructing lymphatic drainage and causing fat malabsorption. Clinical Features: Low-grade fever and joint symptoms, often as the first manifestation. Neurological symptoms in severe cases (CNS involvement is a major concern). Multisystem involvement: Any organ can be affected, sometimes even before gastrointestinal symptoms. Diagnosis: Small bowel biopsy: Characteristic features of foamy macrophages. Polymerase Chain Reaction (PCR) to identify Tropheryma whipplei. Management: Untreated: Often fatal. Initial treatment: Intravenous ceftriaxone (2 g daily for 2 weeks). Follow-up therapy: Oral co-trimoxazole for at least 1 year. Symptom resolution typically occurs quickly, with biopsy changes reverting in weeks. Relapse: Up to 1/3 of patients, often involving the CNS. For relapse: Repeat initial therapy or use doxycycline and hydroxychloroquine . Rheumatoid arthritis (Option A) is a chronic autoimmune disease that primarily affects the joints, causing inflammation, pain, and stiffness but it typically does not present with significant gastrointestinal symptoms such as chronic diarrhea and weight loss. Inflammatory bowel disease (IBD) (Option B) , including Crohn's disease and Ulcerative colitis, also presents with similar symptoms such as chronic diarrhea, abdominal pain, and weight loss but typically presents at a younger age, unlike Whipple’s disease which affects middle-aged and elderly. PAS-positive macrophages are not seen in IBD. Celiac disease (Option D) is an autoimmune disorder characterized by ‘gluten-sensitivity enteropathy’ due to a protein called gluten, which is present in wheat, rye, and barley. It typically presents with chronic diarrhea, abdominal pain, and weight loss, similar to Whipple's disease. Biopsy shows villous atrophy but not PAS-positive macrophages. Serology is positive for anti-tissue transglutaminase antibodies. Reference: Harrison Principles of Internal Medicine, 21st Edition, Page 2464",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Gastrointestinal System-Malabsorption Syndromes"
    },
    {
      "q_no": 6,
      "question": "A 45-year-old male presents with a history of chronic diarrhea, weight loss, arthralgia, and migratory polyarthritis. On examination, he has bilateral lymphadenopathy and a low-grade fever. Laboratory investigations reveal macrocytic anemia, hypoalbuminemia, and elevated erythrocyte sedimentation rate (ESR). Which of the following is incorrect about the causative agent responsible for these clinical findings?",
      "options": {
        "A": "Gram-positive, non-acid fast",
        "B": "PAS-positive",
        "C": "Fluoroquinolones are effective against the causative agent",
        "D": "Cotrimoxazole is used in maintenance therapy in the disease caused by this organism"
      },
      "correct_answer": "C",
      "explanation": "Tropheryma whipplei, a gram-positive, non-acid-fast, periodic acid–Schiff (PAS) positive rod that is ubiquitous in the environment. Fluoroquinolones are ineffective against T. whipplei. Management of Whipple's Disease: Initial phase (IV) Maintenance phase (Oral) Ceftriaxone or Penicillin G for 2 weeks. (OR) Meropenem for 2 to 4 weeks. (In case of ceftriaxone or penicillin allergy) Trimethoprim-sulfamethoxazole (Cotrimoxazole) for one year (Option D ruled out) . (OR) Doxycycline + Hydroxycholoquine for one year. (In case of Sulfa allergy) Reference: Harrison Principles of Internal Medicine, 21st Edition, Page 2464 Q850861",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Gastrointestinal System-Malabsorption Syndromes"
    },
    {
      "q_no": 7,
      "question": "A 50-year-old man presents with a 6-month history of progressive memory loss and confusion. He also complains of intermittent episodes of involuntary eye and facial movements. On examination, he is noted to have supranuclear gaze palsy. His medical history is significant for chronic diarrhea, weight loss, and joint pain. Further investigations reveal periodic acid-Schiff (PAS)-positive macrophages in the cerebrospinal fluid. Which neurological manifestations are considered pathognomonic for the patient’s condition?",
      "options": {
        "A": "Recurrent headaches and visual disturbances",
        "B": "Peripheral neuropathy and autonomic dysfunction",
        "C": "Cerebellar ataxia and ophthalmoplegia",
        "D": "Oculomasticatory myorhythmia and oculofacial myorhythmia"
      },
      "correct_answer": "D",
      "explanation": "suggestive of Classic Whipple’s disease with CNS involvement. CNS involvement is a bad prognosis of Whipple’s disease and is seen in almost 10-40% of patients. Usually, these patients are asymptomatic and can only be diagnosed by PCR detection of Tropheryma whipplei in the CSF, which is gram-positive, non-acid-fast, and periodic acid-Schiff (PAS) positive. In symptomatic patients, the most common neurological symptoms are progressive dementia and confusion. The pathognomic neurological manifestation of Whipple’s disease is Oculomasticatory myorhythmia or oculofacial myorhythmia, always accompanied by Supranuclear vertical gaze palsy and is seen in 20% of the patients. Oculomasticatory myorhythmia is continuous rhythmic movements of eye convergence with concurrent contractions of the masticatory muscles (Pendular nystagmus with masticatory movements). Recurrent headaches and visual disturbances (Option A): Migraine with aura typically presents with recurrent episodes of severe headaches accompanied by visual disturbances such as flashing lights, zigzag lines, or blind spots. These neurological symptoms are typically not seen in Whipple's disease. Peripheral neuropathy and autonomic dysfunction (Option B): Peripheral neuropathy can be seen in Whipple's disease but is not pathognomic. Peripheral neuropathy and autonomic dysfunction are commonly seen in diabetic neuropathy is a common complication of diabetes mellitus characterized by peripheral nerve damage due to chronic hyperglycemia. Cerebellar ataxia and ophthalmoplegia (Option C): These neurological manifestations are seen but not pathognomic of Whipple's disease. The classic triad of confusion, ataxia, and ophthalmoplegia seen in Wernicke's encephalopathy is a neurological disorder caused by thiamine (vitamin B1) deficiency, often seen in alcoholics or malnourished individuals. Reference: Harrison Principles of medicine, 21st Edition, Page 2464 https://www.uptodate.com/contents/whipples-d isease?search=whipples%20disease&source=search_result&selectedTitle=1%7E72&usage_type=default&display _rank=1#H7",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Gastrointestinal System-Malabsorption Syndromes"
    },
    {
      "q_no": 8,
      "question": "A 25-year-old male presents with complaints of bloating, abdominal cramps, and diarrhea that occur consistently within 30 minutes to 2 hours after consuming dairy products. He reports no blood in the stool and denies weight loss or fever. His symptoms started several months ago and are relieved when he avoids milk and milk-based products. Laboratory tests reveal normal complete blood count and inflammatory markers. All of the following are true about this patient's condition except:",
      "options": {
        "A": "It can be confirmed using a hydrogen breath test.",
        "B": "Dietary calcium supplementation may be necessary to prevent deficiencies.",
        "C": "The condition involves an immune-mediated response to dairy proteins.",
        "D": "These patients have elevated luminal lactose levels upon ingestion of lactose."
      },
      "correct_answer": "C",
      "explanation": "deficiency , not an immune-mediated response. Lactose malabsorption : Caused by lactase deficiency, which can be: Primary (genetic) : Adult-type hypolactasia. Secondary : Due to gut damage from infections or diseases. Congenital lactase deficiency : Rare, autosomal recessive disorder, leads to elevated luminal lactose. Mechanism of diarrhea : Patients who are lactase deficient have elevated luminal lactose levels upon ingestion of lactose (Option D ruled out) . Undigested lactose acts as an osmotic substance to draw fluid into the small-bowel lumen, causing watery diarrhea. When unabsorbed lactose enters the colon, luminal bacteria ferment lactose producing intestinal gas (hydrogen, carbon dioxide, and methane), bloating, and abdominal pain. Diagnosis : Initial approach: Lactose-free diet to assess symptom resolution. If unclear, use lactase-tolerance or breath hydrogen test. Lactose tolerance test A predetermined amount of lactose is given → Sugar values are checked. Normal people: Sugar levels are raised to 20 mg In malabsorption: Sugar rise will not occur Breath hydrogen test (Option A ruled out) Evaluation of carbohydrate malabsorption Normal values: <20 ppm Done in fasting state Management : Dietary changes : Exclude lactose, seek alternative calcium and vitamin D sources. Supplements : Consider calcium (Option B ruled out) , vitamin D, and lactase supplements. Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 2463",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Gastrointestinal System-Malabsorption Syndromes"
    },
    {
      "q_no": 9,
      "question": "A 32-year-old woman presents with chronic diarrhea, weight loss, and fatigue for 6 months. She gave a history of traveling to Southeast Asia, where she consumed untreated water. On examination, she is mildly anemic. Laboratory tests show microcytic anemia and low levels of vitamin B12 and folate. A small bowel biopsy reveals mild villous atrophy. Which organism is most commonly associated with this condition?",
      "options": {
        "A": "Yersinia enterocolitica",
        "B": "Campylobacter jejuni",
        "C": "Klebsiella species",
        "D": "Salmonella"
      },
      "correct_answer": "A",
      "explanation": "loss, and malabsorption, with villous atrophy seen on biopsy. Tropical sprue : Chronic diarrhea, steatorrhea, weight loss, and nutritional deficiencies of folate and vitamin B12. Prevalent in some but not all tropical areas, including southern India, Pakistan, the Philippines, Puerto Rico, Haiti, and Cuba. Diagnosis : Requires malabsorption of two unrelated substances. Tropical sprue is suspected only after 3 consecutive stools are negative for ova or trophozoites. Chronic diarrhea is seen in : Yersinia enterocolitica Giardiasis Entamoeba histolytica: Amoebic dysentery, mucosal damage to small bowel, malabsorption Cl. Difficile infection: Prolonged usage of proton pump inhibitors Immunocompromised patients: Rule out cryptosporidium, isospora, strongyloides Small-intestinal biopsy : Abnormal in tropical sprue, resembling celiac disease but with: Less villous alteration. More mononuclear cell infiltration in lamina propria. Crypts hyperplasia may or may not be seen Differentiation from celiac disease : Histologic changes are more uniform across the small intestine; gluten-free diet doesn't improve symptoms or histology. Treatment : Tetracycline + Folic acid supplementation Duration: 6 months Improvement: 1-2 weeks Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 2464, 2465",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Gastrointestinal System-Malabsorption Syndromes"
    },
    {
      "q_no": 10,
      "question": "A 5-year-old child presents with chronic diarrhea, failure to thrive, and progressive night blindness. The child’s mother reports the presence of greasy, foul-smelling stools, and the child has not been gaining weight appropriately for the past year. Physical examination reveals mild abdominal distension. Laboratory studies show low cholesterol, triglycerides, and fat-soluble vitamins E and A. A small bowel biopsy reveals lipid-laden enterocytes. What is the most likely diagnosis?",
      "options": {
        "A": "Familial hypobetalipoproteinemia",
        "B": "Abetalipoproteinemia",
        "C": "Tangier’s disease",
        "D": "MCAD deficiency"
      },
      "correct_answer": "B",
      "explanation": "malabsorption, leading to diarrhea, failure to thrive, and deficiencies in fat-soluble vitamins (E and A). Low serum cholesterol and triglycerides, along with lipid-laden enterocytes on biopsy, are key features. Abetalipoproteinemia : Rare autosomal recessive disorder caused by mutations in the MTTP gene , leading to defective microsomal triglyceride transfer protein (MTP) , which impairs lipid transfer to nascent chylomicrons and VLDLs. Plasma cholesterol and triglycerides are extremely low. Chylomicrons, VLDLs, LDLs, and apoB are undetectable in plasma. Clinical Presentation : Early childhood : Diarrhea, failure to thrive due to fat malabsorption . Neurologic signs : Loss of deep tendon reflexes, ataxia, spastic gait, sensory deficits, and spinocerebellar degeneration (similar to Friedreich's ataxia). Retinopathy : Pigmented retinopathy, starting with night blindness and progressing to color vision loss and blindness . Vitamin Deficiencies : Deficient in vitamins E (severe), A and K . Diagnosis : Genetic testing and lipid analysis to confirm absence of apoB-containing lipoproteins . Biopsy: Lipid-laden enterocytes Spike appearance of RBC: Acanthocytes Treatment : Low-fat, high-calorie, vitamin-enriched diet. High-dose vitamin E supplementation to prevent neurologic sequelae (although it may not fully prevent progression). Familial hypobetalipoproteinemia (Option A) : This condition also involves low levels of apo-B, but it usually causes less severe fat-soluble vitamin deficiencies and is typically less associated with diarrhea and malabsorption. It does not usually lead to the same degree of malabsorption seen in abetalipoproteinemia. Tangier’s disease (Option C) : A very rare lipid storage disorder that involves low levels of HDL cholesterol, but it typically causes neurological issues (like ataxia and peripheral neuropathy) and does not present with severe fat malabsorption or vitamin deficiencies, as seen here. MCAD deficiency (Option D) : Medium-chain acyl-CoA dehydrogenase deficiency is a fatty acid oxidation disorder that can cause hypoglycemia, lethargy, and episodes of vomiting or seizures, especially after fasting. It does not present with chronic diarrhea, steatorrhea, or fat-soluble vitamin deficiencies. Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 3145",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Gastrointestinal System-Malabsorption Syndromes"
    },
    {
      "q_no": 11,
      "question": "A 50-year-old woman presents with chronic diarrhea, bloating, and unintentional weight loss. She has a history of scleroderma, which has caused gastrointestinal motility issues. On examination, she shows signs of vitamin B12 deficiency. Which of the following is NOT a recognized cause of small bowel bacterial overgrowth in this patient?",
      "options": {
        "A": "Scleroderma",
        "B": "Chronic intestinal pseudo-obstruction",
        "C": "Billroth II anastomosis",
        "D": "Chronic pancreatitis"
      },
      "correct_answer": "D",
      "explanation": "motility disorders or anatomical changes that promote stasis, such as scleroderma, chronic intestinal pseudo-obstruction, and Billroth II anastomosis. Chronic pancreatitis leads to digestive enzyme deficiencies and malabsorption, is not a direct cause of SIBO. It does not typically cause stasis or motility issues in the small intestine, which are key mechanisms in the development of bacterial overgrowth. Small Bowel Bacterial Overgrowth Syndrome: Normal bacterial titers: High in terminal ileum. Duodenum < jejunum < ileum However, intestinal disorders affecting motility or causing stasis of bowel contents may lead to small-bowel bacterial overgrowth. Causes : Motility disorders : Scleroderma bowel, chronic intestinal pseudo-obstruction. (Options A & B ruled out) Anatomical abnormalities : Billroth II anastomosis, small-bowel strictures, fibrosis from Crohn’s disease. (Options C ruled out) Surgical resection of the ileocecal valve (leading to increased ileal bacterial counts). Diffuse diverticulosis and fibrosis . Pathophysiology : Bacterial overgrowth deconjugates bile acids , leading to luminal bile acid deficiency . Results in malabsorptive diarrhea with steatorrhea . Damage to the brush border causes carbohydrate maldigestion . Short-chain fatty acid production in the colon causes diarrhea and gas . Vitamin Deficiencies : Vitamin B12 deficiency due to bacterial metabolism, leading to macrocytic anemia and peripheral neuropathy . Elevated serum folate levels from bacterial synthesis. Diagnosis : Duodenal aspirate for bacterial titers (gold standard, but not widely available). Breath hydrogen test using lactulose (common, but must be interpreted carefully to avoid false positives). Treatment : Surgical correction : For blind loops, strictures, or diverticula. Antibiotics : Rifaximin (non-absorbable antibiotic). Other options: Metronidazole, doxycycline, amoxicillin-clavulanic acid, cephalosporins . Treatment duration may be weeks; retreatment or chronic therapy with rotating antibiotics may be required. Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 2461, 2462",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Gastrointestinal System-Malabsorption Syndromes"
    },
    {
      "q_no": 12,
      "question": "Which of the following statements about protein-losing enteropathy (PLE) are correct? PLE can be caused by mucosal ulceration, such as in ulcerative colitis and GI carcinomas, leading to protein loss through damaged mucosa. Lymphopenia may be seen. PLE caused by lymphatic obstruction is most effectively treated with immunosuppressive agents like methotrexate. Alpha-1 antitrypsin testing in stool is diagnostic for PLE, with an elevated level confirming the diagnosis. A diagnosis of PLE is confirmed by measuring serum protein levels, which will show selective loss of only albumin.",
      "options": {
        "A": "1, 2, 3",
        "B": "2, 4, 5",
        "C": "1, 2, 4",
        "D": "2, 3, 4"
      },
      "correct_answer": "C",
      "explanation": "hypoproteinemia and edema, without liver disease (protein synthesis defects) or kidney disease (proteinuria). Causes of PLE: Mucosal ulceration Loss of blood and proteins E.g.: Ulcerative colitis and Crohn's disease Seen in GI carcinoma (Statement 1) Altered blood permeability Crypt hyperplasia – celiac sprue Explains protein loss and muscle wasting Lymphatic dysfunction Enlarged lymph nodes Seen in Non-Hodgkin's lymphoma High protein loss due to obstruction Intestinal lymphangiectasia: Biopsy – Normal enterocytes with dilated lymphatics Clubbing of the villi Diagnosis based on small intestinal mucosal biopsy Cardiovascular causes: Constrictive pericarditis Fontan physiology: Pediatrics Back pressure will affect the lymphatic changes Clinical Features: Diarrhea and peripheral edema. Low serum albumin and globulin levels (excluding liver and kidney diseases). Lymphopenia (loss of CD3+ T cells) may be present, indicating protein loss via lymphatics (Statement 2) . Steatorrhea due to lipid malabsorption from intestinal lymphangiectasia. Diagnostic Methods: Alpha-1 antitrypsin testing in stool (elevated levels suggest protein loss) (Statement 4) . Alpha-1 antitrypsin clearance: Measured through stool and plasma concentrations. Endoscopy and biopsy to rule out mucosal disease. Magnetic resonance enterography for intestinal lymphangiectasia. Treatment: Treat the underlying cause. Low-fat, high-protein diet. Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 2466, 2467",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Gastrointestinal System-Malabsorption Syndromes"
    },
    {
      "q_no": 13,
      "question": "Which of the following is NOT typically used in the initial evaluation of malabsorption?",
      "options": {
        "A": "Stool Sudan III stain",
        "B": "Urinary D-xylose test",
        "C": "MRI enterography",
        "D": "Colonoscopy"
      },
      "correct_answer": "D",
      "explanation": "affect the small intestine , colonoscopy is not typically useful in their evaluation unless another pathology (like IBD or colonic involvement) is suspected. Thus, colonoscopy is not routinely used in the initial workup of malabsorption. Approach to Malabsorption: Patient History GI Symptoms: Abdominal pain Diarrhea Weight loss Bloating Fatigue/weakness Signs of Nutrient Deficiencies: Iron deficiency anemia (nail spooning) Vitamin D & calcium deficiency (bone pain, fractures) Vitamin B12 deficiency (peripheral neuropathy) Protein deficiency (hair loss) Medical History: Chronic pancreatitis Liver disease (primary biliary cholangitis, primary sclerosing cholangitis) Small-bowel resection (e.g., Crohn’s disease, trauma, ischemic bowel disease) Travel History: To rule out infectious causes Risk Factors: Prior GI surgery, infections, or diseases affecting absorption Physical Examination Signs of Nutritional Deficiency: Bitemporal wasting (weight loss) Decreased mid-arm circumference Nail spooning (Iron deficiency anemia) Cheilosis (Vitamin B deficiency) Peripheral neuropathy (Vitamin B12 deficiency) Signs of Malabsorption: Weight loss, edema, bloating, hair loss Laboratory Tests Basic Labs: Hemoglobin (Hb) - To check for anemia Serum ferritin - Iron deficiency anemia INR (Prothrombin time) - Vitamin K deficiency (fat-soluble vitamins) Serum carotene - Fat malabsorption Specific Malabsorption Tests: Stool tests: Sudan III stain - Qualitative test for steatorrhea (fecal fat) Stool elastase - To diagnose pancreatic insufficiency Stool osmolar gap - For osmotic vs secretory diarrhea: 290 – 2 (stool [Na+] + stool [K+]) Osmotic diarrhea: Gap >50-100 Secretory diarrhea: Gap <50 Urinary D-xylose test: Carbohydrate malabsorption (especially for duodenal disease) Excretion <4.5g suggests mucosal damage in the proximal small bowel. Imaging Studies Radiological Exams: Barium small-bowel follow-through - To detect diseases like Crohn’s, celiac, diverticulosis. MRI enterography (MRE) or CT enterography - To assess for inflammatory diseases like Crohn’s disease, strictures, and visualize hepatobiliary system. Endoscopy: Upper endoscopy with small-bowel biopsy - For suspected mucosal disease, e.g., celiac disease, Whipple’s disease, lymphoma. Capsule endoscopy - For visualization of the entire small intestine if endoscopy is inconclusive. Small-bowel enteroscopy Endoscopic Findings and Biopsy Analysis Diffuse Mucosal Pathology: Whipple’s disease: PAS-positive macrophages (diagnosed with immunohistochemistry) Agammaglobulinemia: Reduced plasma cells, normal or flat mucosal architecture Abetalipoproteinemia: Vacuolated enterocytes post-prandially Patchy Lesions: Lymphoma: Malignant cells in lamina propria and submucosa Lymphangiectasia: Dilated lymphatics in submucosa with protein loss (hypoproteinemia) Nonspecific Findings: Villus atrophy: Celiac disease, tropical sprue, bacterial overgrowth Crypt hyperplasia: Celiac sprue, extensive tropical sprue Eosinophilic gastroenteritis: Eosinophilic infiltrate (may be patchy) Confirmatory Diagnosis and Treatment Celiac Disease: IgA tissue transglutaminase (tTG) antibody and IgG deamidated gliadin peptide antibody. Gluten-free diet (monitor with follow-up antibody titers). Whipple's Disease: PAS-positive macrophages in biopsy. Antibiotic therapy (Ceftriaxone + broad-spectrum antibiotics). Tropical Sprue: Clinical diagnosis; biopsy may show villous atrophy. Antibiotics (Empirical treatment with",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Gastrointestinal System-Malabsorption Syndromes"
    }
  ]
}
